Treatment response and gender in patients with schizophrenia and schizoaffective disorder

被引：0
|
作者：
Howard, CH
Fiedosewicz, H
Patel, C
Klegon, DA
Bayog, R
Berman, I
机构：
[1] Harvard Univ, Sch Med, Dept Psychiat, Cambridge, MA 02138 USA
[2] Harvard Univ, Sch Med, Dept Mental Hlth, Cambridge, MA 02138 USA
来源：
SCHIZOPHRENIA RESEARCH | 2001年 / 49卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：232 / 232
页数：1
相关论文
共 50 条
  • [1] Psychopharmacological treatment of patients with schizoaffective disorder in comparison to schizophrenia and bipolar disorder
    Assion, H. J.
    Schweppe, A.
    Skiba, M.
    Juckel, G.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S321 - S322
  • [2] Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response
    Lindenmayer, Jean-Pierre
    Liu-Seifert, Hong
    Kulkarni, Pandurang M.
    Kinon, Bruce J.
    Stauffer, Virginia
    Edwards, Sara E.
    Chen, Lei
    Adams, David H.
    Ascher-Svanum, Haya
    Buckley, Peter F.
    Citrome, Leslie
    Volavka, Jan
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (07) : 990 - 996
  • [3] Treatment with rosuvastatin for severe dyslipidaemia in patients with schizophrenia and Schizoaffective disorder
    De Hert, M.
    Kalnicka, D.
    van Winkel, R.
    Wampers, M.
    Hanssens, L.
    Van Eyck, D.
    Scheen, A.
    Peuskens, J.
    [J]. DRUG SAFETY, 2006, 29 (10) : 1002 - 1002
  • [4] Risperidone versus olanzapine in the treatment of patients with schizophrenia or schizoaffective disorder
    Brecher, M
    [J]. SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 271 - 271
  • [5] Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder
    De Hert, Marc
    Kalnicka, Dita
    van Winkel, Ruud
    Wampers, Martien
    Hanssens, Linda
    Van Eyck, Dominique
    Scheen, Andre
    Peuskens, Joseph
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (12) : 1889 - 1896
  • [6] Treatment with rosuvastatin for severe dyslipidaemia in patients with schizophrenia and schizoaffective disorder
    De Hert, M. A.
    van Winkel, R.
    Wampers, M.
    Van Eyck, D.
    Hanssens, L.
    Scheen, A.
    Peuskens, J.
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 498 - 498
  • [7] Treatment Patterns for Schizoaffective Disorder and Schizophrenia Among Medicaid Patients
    Olfson, Mark
    Marcus, Steven C.
    Wan, George J.
    [J]. PSYCHIATRIC SERVICES, 2009, 60 (02) : 210 - 216
  • [8] The Effect of Delusion and Hallucination Types on Treatment Response in Schizophrenia and Schizoaffective Disorder
    Kilicaslan, Esin Evren
    Acar, Guler
    Eksioglu, Sevgin
    Kesebir, Sermin
    Tezcan, Ertan
    [J]. DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, 2016, 29 (01): : 29 - 35
  • [9] Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder
    Robinson, DG
    Woerner, MG
    Alvir, JMJ
    Geisler, S
    Koreen, A
    Sheitman, B
    Chakos, M
    Mayerhoff, D
    Bilder, R
    Goldman, R
    Lieberman, JA
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (04): : 544 - 549
  • [10] Prediction of response in 160 patients with schizophrenia, schizoaffective and bipolar disorder after olanzapine or risperidone treatment
    Bonaccorso, S.
    Bobo, W. V.
    Chen, Y.
    Jayathilake, K.
    Meltzer, H. Y.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S155 - S156
12345